Cargando…

Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021

BACKGROUND: Vaccination schedules differ from country to country. In France, the diphtheria, tetanus, pertussis, poliomyelitis (dTcaP) booster vaccine coverage for adults aged 25 has been lower than those recommended. We evaluated the impact of an awareness campaign undertaken by the French national...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtaud, Aline, Coomans, Capucine, Vuillemin, Brigitte, Benamar, Akima, Couraud, Maxime, Pham, Bach-Nga, Sanchez, Stéphane, Barbe, Coralie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463893/
https://www.ncbi.nlm.nih.gov/pubmed/37612678
http://dx.doi.org/10.1186/s12913-023-09805-w
_version_ 1785098338797879296
author Hurtaud, Aline
Coomans, Capucine
Vuillemin, Brigitte
Benamar, Akima
Couraud, Maxime
Pham, Bach-Nga
Sanchez, Stéphane
Barbe, Coralie
author_facet Hurtaud, Aline
Coomans, Capucine
Vuillemin, Brigitte
Benamar, Akima
Couraud, Maxime
Pham, Bach-Nga
Sanchez, Stéphane
Barbe, Coralie
author_sort Hurtaud, Aline
collection PubMed
description BACKGROUND: Vaccination schedules differ from country to country. In France, the diphtheria, tetanus, pertussis, poliomyelitis (dTcaP) booster vaccine coverage for adults aged 25 has been lower than those recommended. We evaluated the impact of an awareness campaign undertaken by the French national health insurance system in 2021. METHODS: A randomized, controlled study with adults residing in the Ardennes region was conducted to evaluate the effect on vaccine coverage of the booster vaccine reminder campaign carried out via letter and/or email and/or SMS. The randomization unit was the municipal administrative area (canton). Ten cantons were grouped into the intervention group (INT) and nine were the control group (CON). Outcomes were the booster vaccine delivery and the consultation of a general practitioner (GP) within 12 months (since the French national health insurance running the campaign suggested patients to consult their GP). RESULTS: A total of 1,975 adults were included (INT: 67.3% vs. CON: 32.7%). Of them, 331 received a booster vaccine (INT: 17.4% vs. CON: 15.5%; p = 0.29), and 1,442 consulted a GP (INT: 73.7% vs. CON: 76.8%; p = 0.14). Those who consulted a GP had more frequent vaccine delivery (INT: 19.1% vs. CON: 10.5%; p < 0.0001). CONCLUSIONS: This study found that the awareness campaign run by the French national health insurance did not improve the uptake of the dTcaP booster and that there was a low rate of vaccinated adults aged 25 years. A GP consultation was associated with dTcaP booster vaccine delivery which may show that there is a need of involving GPs in vaccination follow-ups. Patients recognize GPs as providers of credible information and they may play a key role in individualized preventive healthcare actions. Systematic consultations with GPs for follow-up could be proposed to insured adults aged 25 years in the future.
format Online
Article
Text
id pubmed-10463893
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104638932023-08-30 Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021 Hurtaud, Aline Coomans, Capucine Vuillemin, Brigitte Benamar, Akima Couraud, Maxime Pham, Bach-Nga Sanchez, Stéphane Barbe, Coralie BMC Health Serv Res Research BACKGROUND: Vaccination schedules differ from country to country. In France, the diphtheria, tetanus, pertussis, poliomyelitis (dTcaP) booster vaccine coverage for adults aged 25 has been lower than those recommended. We evaluated the impact of an awareness campaign undertaken by the French national health insurance system in 2021. METHODS: A randomized, controlled study with adults residing in the Ardennes region was conducted to evaluate the effect on vaccine coverage of the booster vaccine reminder campaign carried out via letter and/or email and/or SMS. The randomization unit was the municipal administrative area (canton). Ten cantons were grouped into the intervention group (INT) and nine were the control group (CON). Outcomes were the booster vaccine delivery and the consultation of a general practitioner (GP) within 12 months (since the French national health insurance running the campaign suggested patients to consult their GP). RESULTS: A total of 1,975 adults were included (INT: 67.3% vs. CON: 32.7%). Of them, 331 received a booster vaccine (INT: 17.4% vs. CON: 15.5%; p = 0.29), and 1,442 consulted a GP (INT: 73.7% vs. CON: 76.8%; p = 0.14). Those who consulted a GP had more frequent vaccine delivery (INT: 19.1% vs. CON: 10.5%; p < 0.0001). CONCLUSIONS: This study found that the awareness campaign run by the French national health insurance did not improve the uptake of the dTcaP booster and that there was a low rate of vaccinated adults aged 25 years. A GP consultation was associated with dTcaP booster vaccine delivery which may show that there is a need of involving GPs in vaccination follow-ups. Patients recognize GPs as providers of credible information and they may play a key role in individualized preventive healthcare actions. Systematic consultations with GPs for follow-up could be proposed to insured adults aged 25 years in the future. BioMed Central 2023-08-23 /pmc/articles/PMC10463893/ /pubmed/37612678 http://dx.doi.org/10.1186/s12913-023-09805-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hurtaud, Aline
Coomans, Capucine
Vuillemin, Brigitte
Benamar, Akima
Couraud, Maxime
Pham, Bach-Nga
Sanchez, Stéphane
Barbe, Coralie
Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021
title Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021
title_full Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021
title_fullStr Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021
title_full_unstemmed Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021
title_short Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021
title_sort impact of a dtcap booster vaccine awareness campaign initiated by the french national health insurance for adults aged 25 years in 2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463893/
https://www.ncbi.nlm.nih.gov/pubmed/37612678
http://dx.doi.org/10.1186/s12913-023-09805-w
work_keys_str_mv AT hurtaudaline impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021
AT coomanscapucine impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021
AT vuilleminbrigitte impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021
AT benamarakima impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021
AT couraudmaxime impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021
AT phambachnga impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021
AT sanchezstephane impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021
AT barbecoralie impactofadtcapboostervaccineawarenesscampaigninitiatedbythefrenchnationalhealthinsuranceforadultsaged25yearsin2021